AIG
VIR icon

American International Group’s Vir Biotechnology VIR Stock Holding History

American International Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-45,266
Closed -$459K – 2636
2024
Q1 		$459K Sell
45,266
-404
-0.9% -$4.11K ﹤0.01% 1698
2023
Q4 		$459K Sell
45,670
-381
-0.8% -$3.48K ﹤0.01% 1708
2023
Q3 		$431K Buy
46,051
+1,496
+3% +$21.3K ﹤0.01% 1685
2023
Q2 		$1.09M Buy
44,555
+4,755
+12% +$119K 0.01% 1203
2023
Q1 		$926K Buy
39,800
+151
+0.4% +$3.86K 0.01% 1254
2022
Q4 		$1M Sell
39,649
-298
-0.7% -$7.3K 0.01% 1204
2022
Q3 		$770K Buy
39,947
+539
+1% +$13.7K 0.01% 1317
2022
Q2 		$1M Buy
39,408
+9,562
+32% +$223K 0.01% 1197
2022
Q1 		$768K Sell
29,846
-2,100
-7% -$62.3K ﹤0.01% 1489
2021
Q4 		$1.34M Sell
31,946
-957
-3% -$37.5K 0.01% 1253
2021
Q3 		$1.43M Sell
32,903
-781
-2% -$33.8K 0.01% 1220
2021
Q2 		$1.59M Buy
33,684
+2,457
+8% +$112K 0.01% 1243
2021
Q1 		$1.6M Buy
31,227
+82
+0.3% +$4.42K 0.01% 1233
2020
Q4 		$834K Sell
31,145
-894
-3% -$29.1K ﹤0.01% 1489
2020
Q3 		$1.1M Buy
32,039
+3,721
+13% +$160K 0.01% 1202
2020
Q2 		$1.16M Buy
28,318
+24,053
+564% +$807K 0.01% 1144
2020
Q1 		$146K Sell
4,265
-247
-5% -$6.64K ﹤0.01% 2089
2019
Q4 		$57K Buy
+4,512
New +$60.4K ﹤0.01% 2848

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

American International Group's VIR Position: Q2 2024 in Review

American International Group sold out of Vir Biotechnology (VIR) in Q2 2024, closing a stake of 45,266 shares — an estimated $459K sold.

American International Group first reported a position in VIR in Q4 2019 and held it in 18 quarters. The position peaked at $1.6M in Q1 2021. 215 funds tracked by Wall St. Rank hold VIR as of Q2 2024.

  • American International Group reported no remaining Vir Biotechnology position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 45,266 Vir Biotechnology shares in Q2 2024, an estimated $459K.
  • American International Group first reported a position in Vir Biotechnology in Q4 2019 and held it in 18 quarters.
  • American International Group's Vir Biotechnology position peaked at $1.6M in Q1 2021.
  • 215 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.